Search

Author/Creator Hsu, Shih‐Jer

1. Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients. (4th October 2016)

Authors:
Su, Tung‐Hung; Hu, Tsung‐Hui; Chen, Chi‐Yi; Huang, Yi‐Hsiang; Chuang, Wan‐Long; Lin, Chun‐Che; Wang, Chia‐Chi; Su, Wei‐Wen; Chen, Ming‐Yao; Peng, Cheng‐Yuan; Chien, Rong‐Nan; Huang, Yi‐Wen; Wang, Horng‐Yuan; Lin, Chih‐Lin; Yang, Sheng‐Shun; Chen, Tsung‐Ming; Mo, Lein‐Ray; Hsu, Shih‐Jer; Tseng, Ku...
Journal:
Liver international
Issue:
Volume 36:Number 12(2016)
Page Start:
1755
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II). Issue 7 (4th August 2015)

Authors:
Zeuzem, S.; Flisiak, R.; Vierling, J. M.; Mazur, W.; Mazzella, G.; Thongsawat, S.; Abdurakhmanov, D.; Van Kính, N.; Calistru, P.; Heo, J.; Stanciu, C.; Gould, M.; Makara, M.; Hsu, S.‐J.; Buggisch, P.; Samuel, D.; Mutimer, D.; Nault, B.; Merz, M.; Bao, W.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 42:Issue 7(2015)
Page Start:
829
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Ropeginterferon alfa‐2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy. Issue 8 (10th July 2021)

Authors:
Lin, Hsien‐Hong; Hsu, Shih‐Jer; Lu, Sheng‐Nan; Chuang, Wan‐Long; Hsu, Chao‐Wei; Chien, Rong‐Nan; Yang, Sien‐Sing; Su, Wei‐Wen; Wu, Jaw‐Ching; Lee, Tzong‐Hsi; Peng, Cheng‐Yuan; Tseng, Kuan‐Chiao; Qin, Albert; Huang, Yi‐Wen; Chen, Pei‐Jer
Journal:
JGH open
Issue:
Volume 5:Issue 8(2021)
Page Start:
929
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗